To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Division Vote (Commons)
25 Mar 2024 - Investigatory Powers (Amendment)Bill [Lords] - View Vote Context
Jason McCartney (Con) voted No - in line with the party majority and in line with the House
One of 262 Conservative No votes vs 0 Conservative Aye votes
Vote Tally: Ayes - 171 Noes - 265
Division Vote (Commons)
25 Mar 2024 - Investigatory Powers (Amendment)Bill [Lords] - View Vote Context
Jason McCartney (Con) voted No - in line with the party majority and in line with the House
One of 251 Conservative No votes vs 0 Conservative Aye votes
Vote Tally: Ayes - 39 Noes - 257
Division Vote (Commons)
25 Mar 2024 - Investigatory Powers (Amendment)Bill [Lords] - View Vote Context
Jason McCartney (Con) voted No - in line with the party majority and in line with the House
One of 261 Conservative No votes vs 0 Conservative Aye votes
Vote Tally: Ayes - 171 Noes - 265
Division Vote (Commons)
25 Mar 2024 - Investigatory Powers (Amendment)Bill [Lords] - View Vote Context
Jason McCartney (Con) voted Aye - in line with the party majority and in line with the House
One of 252 Conservative Aye votes vs 0 Conservative No votes
Vote Tally: Ayes - 257 Noes - 38
Written Question
Abiraterone
Wednesday 20th March 2024

Asked by: Jason McCartney (Conservative - Colne Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, for what reason abiraterone is not available for free through the NHS in England.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The National Health Service in England funds abiraterone for eligible NHS patients in line with recommendations published by the National Institute for Health and Care Excellence (NICE). It has been recommended by the NICE for the treatment of metastatic hormone-relapsed prostate cancer before chemotherapy is indicated, and for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen.

NHS England is in the process of considering a clinical policy proposal for the use of abiraterone as an off-label treatment option for patients newly diagnosed with high risk, non-metastatic, hormone-sensitive prostate cancer, or in whom prostate cancer has relapsed after at least 12 months without treatment. The policy proposal was sent out to stakeholder testing between the 30 November and 14 December 2023, and will now be considered by NHS England’s Clinical Priorities Advisory Group, who make recommendations on NHS England’s approach to commissioning services, treatments, and technologies, and considers which of these should be prioritised for investment.


Speech in Commons Chamber - Tue 19 Mar 2024
Music Education

Speech Link

View all Jason McCartney (Con - Colne Valley) contributions to the debate on: Music Education

Division Vote (Commons)
19 Mar 2024 - Trade (Comprehensive and Progressive Agreement for Trans-Pacific Partnership) Bill [Lords] - View Vote Context
Jason McCartney (Con) voted No - in line with the party majority and in line with the House
One of 293 Conservative No votes vs 0 Conservative Aye votes
Vote Tally: Ayes - 217 Noes - 305
Division Vote (Commons)
19 Mar 2024 - Trade (Comprehensive and Progressive Agreement for Trans-Pacific Partnership) Bill [Lords] - View Vote Context
Jason McCartney (Con) voted No - in line with the party majority and in line with the House
One of 293 Conservative No votes vs 0 Conservative Aye votes
Vote Tally: Ayes - 218 Noes - 305
Division Vote (Commons)
19 Mar 2024 - Trade (Comprehensive and Progressive Agreement for Trans-Pacific Partnership) Bill [Lords] - View Vote Context
Jason McCartney (Con) voted No - in line with the party majority and in line with the House
One of 296 Conservative No votes vs 0 Conservative Aye votes
Vote Tally: Ayes - 219 Noes - 306
Division Vote (Commons)
19 Mar 2024 - Trade (Comprehensive and Progressive Agreement for Trans-Pacific Partnership) Bill [Lords] - View Vote Context
Jason McCartney (Con) voted No - in line with the party majority and in line with the House
One of 298 Conservative No votes vs 0 Conservative Aye votes
Vote Tally: Ayes - 224 Noes - 301